4 No source found (not proven false)
In natural fertility cohorts, the monthly probability of pregnancy for nulliparous women is approximately 20% at age 30, 11-12% at ages 35-36, 5% at age 38, and 3% at age 40 and older.
"Meaning, if I will sit here and say if you're trying to get pregnant with your first child and you're 30, you'll have a 20% chance per month, right? The finest point we look at in natural fertility studies is called fecundability, the probability of pregnancy per month. But as you age, when you're 35 to 36, that number will be 11 to 12% per month. At age 38, it'll be 5% per month. And at 40 and beyond, it'll be 3% per month." (said at 0:23:44)
While natural fertility literature broadly demonstrates a progressive decline in per-cycle fecundability with advancing maternal age, the specific point estimates cited by the speaker (approx. 20% per month at age 30, 11–12% at ages 35–36, 5% at age 38, and 3% at age 40 and older for nulliparous women) could not be verified against the abstracts retrieved within the search session. This does not establish that the figures are false, but that matching published cohort data confirming these exact age-specific probabilities was not located in the fetched records.
Among couples who successfully conceive, approximately 72% achieve pregnancy in the first 6 months of trying, and 13% conceive in the subsequent 6 months.
"most people who do will get pregnant the first 6 months. So, 72% of people will get pregnant in that first 6 months of trying and only 13% will get pregnant in the next 6 months of trying." (said at 0:25:40)
No matching published study reporting the exact breakdown of 72% of couples conceiving in the first 6 months and 13% in the subsequent 6 months was located in the retrieved records. In general reproductive epidemiology literature, cumulative pregnancy rates for couples trying to conceive naturally are typically cited as approximately 70-75% by 6 months and 80-85% by 12 months (an additional 10-15% in months 7-12), which is consistent with the speaker's overarching point, but the specific statistical source for the exact 72% and 13% figures could not be verified.
A female fetus has 6 to 7 million eggs at 5 months of gestation, which decreases to 1 to 2 million at birth and to approximately 500,000 at menarche.
"You have the most eggs when you're 5 months old inside your mom. You have 6 to 7 million eggs. By the time that you're born, you have 1 to 2 million. By the time you start your first period, you have half a million." (said at 0:42:05)
No published records were successfully retrieved within the search constraints to directly verify the specific figures cited. Although standard human reproductive embryology literature (such as classic morphometric work by Baker and subsequent ovarian reserve modeling) classically describes peak oogonia/oocyte counts of approximately 6 to 7 million at 20 weeks (5 months) of gestation, declining via atresia to 1 to 2 million at birth and 300,000 to 500,000 around menarche/puberty, no fetched PubMed records were obtained during the search to formally cite. This does not prove the claim false.
An out-of-pocket AMH blood test costs $79.
"$79. A $79 test, and I I feel really strongly about this." (said at 0:56:07)
No peer-reviewed publications matching the specific claim of a $79 out-of-pocket Anti-Müllerian Hormone (AMH) test cost were identified in PubMed. While direct-to-consumer (DTC) and out-of-pocket laboratory testing for AMH is widely available through commercial vendors and clinical laboratories (where retail and cash prices vary widely, typically ranging from ~$60 to over $150 depending on the provider and laboratory fees), specific commercial pricing is not standardized or documented as a fixed benchmark in published biomedical literature. This does not mean the price is false for specific commercial vendors, but it is unverified in published scientific records.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.